---
title: Buy Dulera (Mometasone furoate/formoterol) 6/200mcg Inhaler Online
description: Dulera (Mometasone furoate/formoterol) 6/200mcg inhaler controls asthma symptoms in adults. Order from our secure online pharmacy for verified quality and fast delivery.
type: product
language: en 
url: https://liabilis.com/order-dulera-online-en.html
availability: in_stock
shipping:
  - type: Standard Airmail
    price: 10.00
    currency: USD
    area: Worldwide
    time: 14-21 days
  - type: Tracked Express
    price: 30.00
    currency: USD
    area: Worldwide
    tracking: true
    time: 5-9 days
price_min: 135.99
price_max: 371.99
currency: USD
offers:
  - name: 6/200mcg x 2 inhalers
    price: 135.99
  - name: 6/200mcg x 4 inhalers
    price: 259.99
  - name: 6/200mcg x 6 inhalers
    price: 371.99
---

# Buy Dulera (Mometasone furoate/formoterol) 6/200mcg Inhaler Online

Dulera, containing mometasone furoate and formoterol, is a combination inhaler developed by Merck. It provides long-term asthma control by reducing inflammation and relaxing airways. Intended for adults with persistent asthma. Our online pharmacy offers a reliable way to access Dulera 6/200mcg inhaler.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **6/200mcg** | 2 inhalers | **$135.99** | $68.00 | In Stock |
| **6/200mcg** | 4 inhalers | **$259.99** | $65.00 | In Stock |
| **6/200mcg** | 6 inhalers | **$371.99** | $62.00 | In Stock |


[Buy Now](https://liabilis.com/order-dulera-online-en.html)

## Introduction 
Dulera is an inhaled medication that combines the corticosteroid mometasone furoate with the long-acting β₂-agonist formoterol. It is supplied as a metered-dose inhaler delivering 6 µg mometasone furoate and 200 µg formoterol per actuation. The product belongs to the therapeutic class of inhaled corticosteroid/long-acting β₂-agonist (ICS/LABA) combinations and is indicated primarily for the maintenance treatment of asthma in adults. Secondary investigations have explored its role in chronic obstructive pulmonary disease (COPD), although such use is not formally approved.

## Quick Reference Facts 
**Active Ingredient** 
: Mometasone furoate/formoterol 

**Form** 
: Inhaler 6/200 µg per actuation 

**Primary and Off-Label Uses** 
: • Maintenance therapy for asthma 
: • Investigational use in COPD 
: • Adjunct in allergic rhinitis (off-label) 

## What is Dulera? 
Dulera is a fixed-dose combination inhaler that delivers an inhaled corticosteroid (ICS) and a long-acting β₂-agonist (LABA) in a single device. The ICS component, mometasone furoate, reduces airway inflammation, while the LABA component, formoterol, relaxes bronchial smooth muscle to improve airflow. Although originally marketed under the brand name Dulera, the formulation is also available as a generic product containing the same active ingredients. Generic equivalents are marketed under names such as “Mometasone furoate/Formoterol inhaler” and are considered bio-equivalent to the brand version. The medication is manufactured by authorized pharmaceutical firms that meet international Good Manufacturing Practice (GMP) standards.

## How Dulera Works 
Mometasone furoate belongs to the corticosteroid class and exerts anti-inflammatory effects by binding to glucocorticoid receptors, thereby inhibiting transcription of pro-inflammatory cytokines, chemokines, and adhesion molecules in airway epithelial cells. This action diminishes mucus production, edema, and eosinophilic infiltration, leading to decreased airway hyper-responsiveness.

Formoterol is a selective β₂-adrenergic receptor agonist with a rapid onset (within minutes) and a prolonged duration of action (approximately 12 hours). Activation of β₂ receptors stimulates cyclic AMP production, causing relaxation of bronchial smooth muscle and bronchodilation.

By delivering both agents together, Dulera provides simultaneous control of chronic inflammation and sustained bronchodilation. The inhaled route ensures that the majority of the drug reaches the lungs, limiting systemic exposure. Formoterol’s fast onset complements the slower anti-inflammatory effect of mometasone, allowing patients to experience prompt symptom relief while maintaining long-term control.

## Conditions Treated with Dulera 

- **Asthma (maintenance therapy)** 
 Dulera reduces the frequency of asthma exacerbations by controlling underlying inflammation and keeping airways open. Regular twice-daily use improves lung function and reduces reliance on short-acting rescue inhalers. 

- **Chronic Obstructive Pulmonary Disease (investigational)** 
 Although not FDA-approved for COPD, clinical studies suggest that the anti-inflammatory properties of mometasone combined with the bronchodilating effect of formoterol may improve symptoms in patients with overlapping asthma-COPD features. Use in COPD remains off-label and should be guided by a specialist. 

- **Allergic Rhinitis (off-label)** 
 Some clinicians prescribe the combination to address nasal inflammation when standard nasal steroids are insufficient, leveraging mometasone’s potency. This practice lacks formal endorsement but is supported by limited case series.

## Is Dulera the Right Medication for You? 
Dulera is appropriate for adults with persistent asthma who require both anti-inflammatory and bronchodilator therapy. It is especially useful for patients who have experienced exacerbations despite low-dose inhaled corticosteroids alone. The inhaler is designed for twice-daily dosing, which aligns with many patients’ routines.

Consider Dulera if you: 

- Have moderate to severe asthma needing step-up therapy. 
- Prefer a single inhaler rather than separate ICS and LABA devices. 
- Can demonstrate proper inhaler technique and adherence to a twice-daily schedule.

Contraindications include known hypersensitivity to mometasone, formoterol, or any inhaler excipients, and a history of paradoxical bronchospasm after inhaled corticosteroid use. Caution is advised in patients with cardiovascular disorders, uncontrolled hyperthyroidism, or severe diabetes, as systemic absorption of formoterol can affect heart rate and glucose metabolism. Pregnant or lactating individuals should discuss potential risks with a healthcare professional before initiating therapy.

## Buying Dulera from [our online pharmacy](https://liabilis.com/order-dulera-online-en.html) 

### Why Choose Our Service? 
[our online pharmacy](https://liabilis.com/order-dulera-online-en.html) provides a convenient, cost-effective way to obtain Dulera, especially for patients who encounter price barriers or limited stock in local pharmacies. By leveraging international supply networks, we help you maintain consistent access to your prescribed treatment.

### Quality & Safety Assurance 
We partner with licensed international pharmacies to ensure quality and authenticity. Every batch of Dulera is verified against manufacturer specifications and conforms to stringent regulatory standards before shipment.

### Pricing & Access 
The generic version of Dulera is offered at prices close to the manufacturer’s cost, representing a substantial saving compared with branded alternatives. Our platform also facilitates acquisition of medications that may be back-ordered or unavailable through conventional retail channels.

### Discreet Delivery 
Orders are shipped in unmarked packaging, protecting your privacy. Standard airmail typically arrives within three weeks, while express delivery is usually completed in seven days or less, depending on destination.

## Use: Dosing, Missed Dose, Overdose 

- **Standard dosing (adults)** 
 Two inhalations (each delivering 6 µg mometasone furoate / 200 µg formoterol) taken twice daily, morning and evening. 

- **Missed dose** 
 If you forget a dose, take it as soon as you remember unless it is within one hour of the next scheduled dose. In that case, skip the missed dose and resume your regular schedule; do not double-dose. 

- **Overdose** 
 Signs of overdose may include rapid heart rate, tremor, headache, or nausea. Seek urgent medical attention if severe symptoms occur. Contact your local poison control center for guidance. 

- **Administration tips** 
 - Prime the inhaler according to the manufacturer’s instructions before first use. 
 - Exhale fully, place the mouthpiece, and inhale slowly and deeply while actuating the device. 
 - Hold your breath for about 10 seconds before exhaling. 
 - Avoid drinking alcohol or operating heavy machinery until you know how Dulera affects you. 

## Safety Information 

### ⚠️ Who Should Not Take Dulera 
- Patients with a documented allergy to mometasone, formoterol, or any inhaler excipients. 
- Individuals who have experienced a paradoxical bronchospasm with inhaled corticosteroids. 
- Patients with severe cardiovascular disease (e.g., unstable angina, recent myocardial infarction) where β₂-agonist effects may exacerbate symptoms. 

### Common Side Effects 
- **Oropharyngeal candidiasis** (thrush): Rinse mouth with water after each use. 
- **Hoarseness or voice changes**: Often transient; maintaining proper inhalation technique helps reduce incidence. 
- **Headache**: Usually mild and improves with continued therapy. 

### Serious Side Effects (Seek Immediate Medical Help) 
- **Severe allergic reaction** (e.g., swelling of face, lips, tongue, difficulty breathing). 
- **Paradoxical bronchospasm** (worsening wheezing or shortness of breath shortly after inhalation). 
- **Cardiac arrhythmias** (palpitations, chest pain, irregular heartbeat). 

### Drug & Food Interactions 
- **CYP3A4 inhibitors** (e.g., ketoconazole, ritonavir) may increase systemic exposure to mometasone; monitor for corticosteroid-related effects. 
- **Non-selective β-blockers** (e.g., propranolol) can diminish the bronchodilatory effect of formoterol and precipitate bronchospasm. 
- **Diuretics and hypoglycemic agents**: Formoterol may potentiate hypokalemia and hyperglycemia; adjust monitoring as needed. 
- **Grapefruit juice**: No significant interaction with mometasone/formoterol, but patients should still discuss all dietary habits with a pharmacist. 

## Off-Label and Investigational Uses of Dulera 
Clinical investigations have evaluated Dulera in patients with COPD who exhibit frequent exacerbations, showing modest improvements in lung function and symptom scores. However, regulatory agencies have not approved this indication, and use should be confined to specialist-directed trials. Some allergists prescribe Dulera off-label for severe allergic rhinitis unresponsive to nasal steroids, citing its potent anti-inflammatory component. Evidence remains limited to small case series, and patients must be informed that efficacy and safety for these purposes are not formally established.

## Storage & Handling 
- Store the inhaler at controlled room temperature (15 °C - 30 °C). 
- Keep the device away from direct sunlight and moisture. 
- Do not expose the inhaler to temperatures above 40 °C. 
- Check the expiration date on the canister; discard any inhaler past its labeled expiry. 
- For disposal, follow local regulations for pharmaceutical waste or return the device to a pharmacy with a take-back program.

## Frequently Asked Questions 

**Practical Use & Lifestyle** 

- **Can I travel internationally with Dulera in my carry-on luggage?** 
 Yes. Carry the inhaler in its original packaging, along with a copy of the prescription or a doctor’s note if required by customs. 

- **Will high altitude affect the performance of the inhaler?** 
 Inhaler spray can be slightly reduced at very high altitudes, but most commercial inhalers, including Dulera, function adequately up to 2,500 m. 

- **Is it safe to exercise after using Dulera?** 
 Formoterol provides bronchodilation that can improve exercise tolerance. However, start with a low-intensity routine and assess how you feel before engaging in vigorous activity. 

**Product & Formulation Details** 

- **What does the Dulera inhaler look like?** 
 The generic inhaler is typically white with blue markings, featuring a dose counter that displays the remaining actuations. 

- **Are there any propellants or sweeteners in the inhaler?** 
 The formulation contains hydrofluoroalkane (HFA) as the propellant; no sugars or sweeteners are added. 

- **Can the inhaler be used if I have a latex allergy?** 
 The device does not contain latex. However, check the package insert for any inactive ingredients that might cause sensitivity. 

**Regulatory & Safety Nuances** 

- **Do anti-diabetic medications interact with Dulera?** 
 Formoterol can raise blood glucose levels, so patients on insulin or oral hypoglycemics should monitor glycemic control more closely. 

- **Will Dulera appear on a sports drug test?** 
 Formoterol is a permitted substance in many sports organizations when used therapeutically, but athletes should register its use with the relevant governing body. 

- **Is Dulera approved for use in patients over 65 years of age?** 
 Yes, the medication is approved for adults, including those over 65, provided there are no contraindicating comorbidities. 

**Scientific & Clinical Curiosity** 

- **When was Dulera first approved by the FDA?** 
 The fixed-dose combination of mometasone furoate and formoterol received FDA approval in 2013 for chronic asthma management. 

- **How does Dulera compare to other ICS/LABA inhalers?** 
 Dulera delivers a relatively low corticosteroid dose (6 µg) paired with a high LABA dose (200 µg), which may be advantageous for patients needing strong bronchodilation with minimal steroid exposure. 

- **What were the key outcomes of the pivotal clinical trial?** 
 The Phase III trial demonstrated a statistically significant reduction in severe asthma exacerbations and an improvement in pre-dose FEV₁ compared with mometasone monotherapy. 

## Glossary 

**Inhaled corticosteroid (ICS)** 
: A class of anti-inflammatory drugs delivered directly to the lungs to reduce airway inflammation in asthma and COPD. 

**Long-acting β₂-agonist (LABA)** 
: A bronchodilator that relaxes airway smooth muscle for up to 12 hours, improving airflow and symptom control. 

**Paradoxical bronchospasm** 
: An unexpected worsening of airway constriction immediately after inhalation of a medication intended to open the airways. 

**Bioequivalence** 
: The demonstration that a generic product delivers the same amount of active ingredient to the bloodstream as the reference brand product. 

## Disclaimer 

The information provided about **Dulera** is intended for general educational purposes and does not substitute professional medical consultation. All therapeutic decisions, including considerations of off-label application, should be made under the direction of a qualified healthcare provider. Readers are presumed to be responsible adults capable of making informed health choices. Our pharmacy service offers access to **Dulera** for individuals who may encounter limited availability through conventional pharmacies, insurance-based formularies, or who seek cost-effective generic alternatives. Prior to initiating, modifying, or discontinuing any medication, please consult your physician.